Name | Value |
---|---|
Revenues | 0.0K |
Cost of Revenue | 138.0K |
Gross Profit | -138.0K |
Operating Expense | 5,349.0K |
Operating I/L | -5,349.0K |
Other Income/Expense | 348.0K |
Interest Income | 44.0K |
Pretax | -5,001.0K |
Income Tax Expense | -348.0K |
Net Income/Loss | -5,001.0K |
Hancock Jaffe Laboratories, Inc. is a medical device company specializing in developing biologic-based solutions for cardiovascular and venous diseases. Their focus is on creating tissue-based products that are designed to be life enhancing for patients with conditions such as cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease. The company's main products include the Bioprosthetic Heart Valve (BHV), a pig heart valve designed to function like a native heart valve, and the Venous Valve, a pig venous valve for patients with lower limb chronic venous insufficiency (CVI) caused by damage to the valves of the veins in the legs after developing blood clots in the deep venous system.